Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes

Diabetologia - Germany
doi 10.1007/s00125-009-1505-6
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Sulforaphane Reduces Hepatic Glucose Production and Improves Glucose Control in Patients With Type 2 Diabetes

Science Translational Medicine
Medicine
2017English

Glucose Control and Fatigue in Type 2 Diabetes: The Mediating Roles of Diabetes Symptoms and Distress

Journal of Advanced Nursing
Nursing
2015English

Microvascular Outcomes in Type 2 Diabetes

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Effects of Intensive Control of Glycemia on Clinical Kidney Outcomes in Type 2 Diabetes Patients Compared With Standard Control: A Meta-Analysis

Frontiers in Pharmacology
Pharmacology
2017English

A1C and Cardiovascular Outcomes in Type 2 Diabetes: A Nested Case-Control Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Postmenopausal Symptoms in Female Veterans With Type 2 Diabetes: Glucose Control and Symptom Severity

Journal of Women's Health
Medicine
2015English

Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes

Therapeutics and Clinical Risk Management
2018English

Macrovascular Complication Phenotypes in Type 2 Diabetic Patients

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy